MedPath

SINGAPORE EYE RESEARCH INSTITUTE

🇸🇬Singapore
Ownership
Private
Established
1997-01-01
Employees
-
Market Cap
-
Website
http://www.seri.com.sg

Clinical Trials

21

Active:1
Completed:7

Trial Phases

4 Phases

Phase 1:2
Phase 3:5
Phase 4:1
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (15 trials with phase data)• Click on a phase to view related trials

Not Applicable
7 (46.7%)
Phase 3
5 (33.3%)
Phase 1
2 (13.3%)
Phase 4
1 (6.7%)

Validation of the Use of Terahertz Scanning System on Corneal Scars and Corneal Edema

Recruiting
Conditions
Corneal Diseases
Corneal Scars and Opacities
Corneal Edema
First Posted Date
2025-05-21
Last Posted Date
2025-05-21
Lead Sponsor
Singapore Eye Research Institute
Target Recruit Count
150
Registration Number
NCT06983652
Locations
🇸🇬

Singapore National Eye Centre, Singapore, Singapore

Evaluation of the Safety of Terahertz Scanning System on Corneas

Recruiting
Conditions
Corneal Diseases
First Posted Date
2025-05-13
Last Posted Date
2025-05-16
Lead Sponsor
Singapore Eye Research Institute
Target Recruit Count
5
Registration Number
NCT06967792
Locations
🇸🇬

Singapore National Eye Centre, Singapore, Singapore

Artificial Intelligence (AI) - Assisted Visual Impairment Screening Model: Community-based Implementation and Evaluation of Performance, Feasibility and Costs.

Not Applicable
Recruiting
Conditions
Visual Impairment
First Posted Date
2025-03-14
Last Posted Date
2025-05-14
Lead Sponsor
Singapore Eye Research Institute
Target Recruit Count
400
Registration Number
NCT06877988
Locations
🇸🇬

Pioneer Polyclinic, Singapore, Singapore

Comparison of Femto LDV Z8 Corneal Lenticule Extraction for Advanced Refractive Correction (CLEAR) and Visumax Small Incision Lenticule Extraction (SMILE)

Recruiting
Conditions
Myopia
First Posted Date
2025-01-14
Last Posted Date
2025-01-14
Lead Sponsor
Singapore Eye Research Institute
Target Recruit Count
65
Registration Number
NCT06774651
Locations
🇸🇬

Singapore National Eye Centre, Singapore, Singapore

Nicotinamide Supplementation in Glaucoma

Phase 3
Conditions
Glaucoma
First Posted Date
2024-12-12
Last Posted Date
2024-12-12
Lead Sponsor
Singapore Eye Research Institute
Target Recruit Count
520
Registration Number
NCT06731582
Locations
🇸🇬

National University Hospital, Singapore, Central Singapore, Singapore

🇸🇬

Singapore Eye Research Institute, Singapore, Central Singapore, Singapore

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

News

Faricimab Shows Superior Fluid Reduction and Sustained Efficacy in Wet AMD Through 3-Year Data

Real-world TRUCKEE study data demonstrates faricimab maintains vision and fluid status through 3 years in wet AMD patients, with benefits increasing over continuous treatment and potential for extended treatment intervals.

© Copyright 2025. All Rights Reserved by MedPath